GGrantIndex
← Search

TARGETING AN AMPHIREGULIN NEOEPITOPE TO ERADICATE ENDOCRINE-RESISTANT BREAST CANCER CELLS

$1,168,998FY2014Department of the ArmyDOD

Gundersen Lutheran Medical Foundation, Inc.

Investigators

View source on USAspending →
TARGETING AN AMPHIREGULIN NEOEPITOPE TO ERADICATE ENDOCRINE-RESISTANT BREAST CANCER CELLS · GrantIndex